The premise of this business is the same tho. Selling units to hospitals by direct sale channels. I read your answer a few times. Hard to value patents/ intangibles. When patents eventually expire the company can’t stop third parties using them. Marketing approvals are fine but the demand for new units is steady (at best). Historically UCM has always been on the cusp of a change in demand. That hasn’t changed either. You’re saying 1-2 years but time will tell.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 26/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable